Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2351
Last updated 2014-09-25
Summary
A cohort of 3000 adults is followed to evaluate the effectiveness of the monovalent 2009 H1N1 vaccines used 2009-2010 and seasonal influenza vaccines used 2010-2011 in preventing the first laboratory-confirmed 2009 H1N1 influenza during the influenza season 2010-11.
Conditions
- Influenza Caused by the 2009 H1N1 Influenza Virus
Interventions
- OTHER
-
Follow-up
Questionnaires, interviews, nasal/oral and serum samples, register data
- OTHER
-
Follow-up
Questionnaires, interviews, nasal/oral and serum samples, register data
Sponsors & Collaborators
-
Finnish Institute for Health and Welfare
lead OTHER_GOV
Principal Investigators
-
Terhi M Kilpi, MD, PhD · Finnish Institute for Health and Welfare
Eligibility
- Min Age
- 18 Years
- Max Age
- 76 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2011-04-30
- Completion
- 2014-09-30
Countries
- Finland
Study Locations
More Related Trials
-
Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines
NCT00644059 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)
NCT01138397 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
NCT00979602 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10
NCT00992212 ·Status: COMPLETED ·Phase: PHASE2
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route)
NCT01121822 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of H1N1 Influenza Vaccines in Manitoba, Canada
NCT01622491 ·Status: UNKNOWN
-
Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults
NCT00989287 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years
NCT00616928 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
NCT01201902 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation
NCT00946179 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
NCT00968526 ·Status: COMPLETED ·Phase: PHASE3
-
Persistence of Immune Response After Vaccination With Influenza Vaccine
NCT01906190 ·Status: COMPLETED ·Phase: NA
-
H1N1 Vaccine Safety in Manitoba, Canada
NCT01421251 ·Status: UNKNOWN
-
A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years
NCT00956202 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
NCT00311428 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Age on Response to the 2009 H1N1 Virus Vaccine
NCT01055184 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults
NCT01258062 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
NCT01022905 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults
NCT01059617 ·Status: COMPLETED ·Phase: PHASE1
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older
NCT00985088 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)
NCT00945438 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine
NCT01000584 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of V70P5 Revaccination Subjects
NCT01210898 ·Status: COMPLETED ·Phase: PHASE3